Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis

Suggested Citation

Edler P., Rajasekhar M., Price D.J., Adam I., Awab G.R., Barber B.E., Brasil L.W., Chamma-Siqueira N.N., Chu C.S., Cui L., Daher A., Gomes M.d.S.M., Gonzalez-Ceron L., Grigg M.J., Karunajeewa H., Lacerda M.V.G., Ladeia-Andrade S., Leslie T., Ley B., Lidia K., Llanos-Cuentas A., Longley R.J., Manning L., Mekonnen D.A., Monteiro W.M., Moore B.R., Nosten F., Pasaribu A.P., Pereira D.B., Poespoprodjo J.R., Pukrittayakamee S., Rijal K.R., Saravu K., Siqueira A.M., Sutanto I., Taylor W.R.J., Thanh P.V., Thriemer K., Vieira J.L.F., White N.J., Yeshiwondim A.K., Zuluaga-Idarraga L.M., Guerin P.J., Simpson J.A., Price R.N., Commons R.J. Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. Malaria Journal Vol.24 No.1 (2025) , 400. doi:10.1186/s12936-025-05642-w Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/113201

Availability

Collections